Correlation between histopathological response by neoadjuvant DCF therapy and the clinical efficacy of palliative platinum-containing regimens for recurrent ESCC.

Authors

null

Shota Igaue

Department of Esophageal Surgery, National Cancer Center Hospital, Tokyo, Japan

Shota Igaue , Shun Yamamoto , Kazuhiro Shiraishi , Akihiro Ohara , Mai Itoyama , Kazuki Yokoyama , Yoshitaka Honma , Tairo Kashihara , Daisuke Kurita , Koshiro Ishiyama , Junya Oguma , Hiroyuki Daiko , Ken Kato

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 272)

DOI

10.1200/JCO.2024.42.3_suppl.272

Abstract #

272

Poster Bd #

C10

Abstract Disclosures

Similar Posters

First Author: Jun Okui

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.

Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.

First Author: Yuri Yoshinami

First Author: Toshiharu Hirose